Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models

BackgroundSevere radiation-induced lymphopenia (RIL) in patients undergoing chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC) is associated with decreased immunotherapy efficacy and survival. At The Christie and MD Anderson Cancer Center (MDACC), prediction models for lymphopenia were d...

Full description

Bibliographic Details
Main Authors: Peter S. N. van Rossum, Celia Juan-Cruz, Barbara Stam, Maddalena M. G. Rossi, Steven H. Lin, Azadeh Abravan, José S. A. Belderbos, Jan-Jakob Sonke
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
lung cancer
radiotherapy
chemoradiotherapy
lymphopenia
hematologic toxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1278723/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1278723/full

Similar Items